Full Version | Search

The Irish Medicines Board - www.imb.ie

IMB Logo

Sabril (vigabatrin) - Important Safety Information from sanofi-aventis as approved by the Irish Medicines Board

05 July 2010

Important safety information communication from sanofi-aventis on abnormal brain MRI findings and movement disorders in patients treated with Sabril® (Vigabatrin).

Important Safety Information - Sabril (vigabatrin)





Date Printed: 22 May 2013

© Irish Medicines Board 2013 | Developed by Engine Solutions www.engine.ie

Address: Kevin O'Malley House, Earlsfort Centre, Earlsfort Terrace, Dublin 2, Ireland.
Tel: 353-1-676 4971